Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
ERICH PLATZER Insider Profile
11 Followers
ERICH PLATZER, Director at CTI BioPharma, holds ― shares in CTI BioPharma (Ticker: CTIC), holds 405.00K shares in Aptose Biosciences (Ticker: APTO). Most recently, ERICH PLATZER ― shares of CTI BioPharma on ― for an estimated value of ―.
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-0.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that ERICH PLATZER holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 20, 2019 - Mar 20, 2020
Return:+130.50%
The most profitable trade made by ERICH PLATZER
ERICH PLATZER's Trading History
CTI BioPharma
―
―
―
―
Aptose Biosciences
Dec 20, 2021
Director
Informative Buy
137.90K
$498.15K
List of latest transactions for each holding click on a transaction to see ERICH PLATZER's performance on stock
You May Also Like
ERICH PLATZER insider profile FAQ
What is the percentage of profitable transactions made by ERICH PLATZER?
The percentage of profitable transactions made by ERICH PLATZER is 33%.
What is the average return per transaction made by ERICH PLATZER?
The average return per transaction made by ERICH PLATZER is -0.10%.
What stocks does ERICH PLATZER hold?
ERICH PLATZER holds: CTIC, APTO stocks.
What was ERICH PLATZER’s latest transaction?
ERICH PLATZER latest transaction was an Uninformative Buy of ―.
What was ERICH PLATZER's most profitable transaction?
ERICH PLATZER’s most profitable transaction was an Informative Buy of APTO stock on March 20, 2019. The return on the trade was 130.50%.
What is ERICH PLATZER's role in CTI BioPharma?
ERICH PLATZER's role in CTI BioPharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.